Natera Stock News & Updates

[WKN: A14VPJ | Symbol: 45E]

Natera

Natera: Diagnostic Specialist Grows 38% in Q2 - Price Jumps to a new all-Time High

08/07/2026 at 04 PM

Q2 revenue grows by 37.7% to $752.8 million with a gross margin of 64.5%. Nearly 297,000 processed...

06/29/2026 at 10 AM

Natera's business model is based on genetic testing through non-invasive blood analyses used in oncology,...

06/26/2026 at 10 AM

Natera (NTRA, i) is an exciting diagnostics company that is likely to achieve trend continuation with...

11/25/2025 at 02 PM

Business Drivers: Natera (NTRA) specializes in genetic tests for the detection of serious and life-threatening...

11/25/2025 at 11 AM

Natera has a proprietary cfDNA platform that enables non-invasive, highly accurate diagnostic tests...

11/21/2025 at 12 PM

Blood instead of biopsy: customized DNA blood tests for cancer, pregnancy, and transplants – with...

10/24/2025 at 06 PM

Business drivers: Natera (NTRA) specializes in genetic testing for the detection of serious and life-threatening...

09/03/2025 at 01 PM

Adidas [DE000A1EWWW0] JPMorgan places the stock on the "Positive Catalyst Watch" - the price...

04/25/2025 at 12 PM

Meanwhile, we are seeing more and more tradeable setups again, with many stocks showing signs of a double...

03/13/2025 at 01 PM

IREN [AU0000185993]: JPMorgan upgrades from Neutral to Overweight, but lowers the price target from $15...